제이브이엠

054950KOSDAQ

66.3 / 100

Reference Date: 2026-09-08

Financial Score29.0 / 40

News Sentiment21.3 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health and PER is significantly undervalued vs. peers is also solid. Declined 5.7% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Jevem develops and sells cutting-edge automated pharmacy systems for hospitals and pharmacies, streamlining tasks such as medication management, sorting, distribution, and packaging to enhance pharmaceutical efficiency. Key products include ATDPS, VIZEN EX, WIZER, and INTIPharm, with international expansion supported by partnerships with Hanmi Pharm and Sinopharm.

Number of Employees

322people

Average Salary

67.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

9.51Industry Average 15.006.5Point

Lower than industry avg (good)

PBR

1.21Industry Average 1.202.5Point

Higher than industry avg (caution)

ROE

13.00Industry Average 8.005.5Point

1.6x industry avg (good)

Debt Ratio

3.18Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20256.5 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲5.0% (2-year basis)

Operating Profit Growth Rate

2.0 / 3

Avg ▲5.8% (2-year basis)

ROE Trend

2.5 / 4

Avg ROE 14.6% (declining, 3yr)

Detailed News Sentiment

1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 85

Positive
제이브이엠, 수익성 개선 가속…성장 이어갈 3박자는
제이브이엠의 해외 판매 확대와 신제품 출시로 수익성 개선이 가속화되고 있다.

Detailed Momentum

52-week position3.0Point

52w lower range (24%)

Current 23,400Won52-week high 33,80052-week low 20,000

1-month return2.0Point

1m -5.65% (slight drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral기업설명회(IR)개최2026-08-20
Neutral반기보고서 (2026.06)2026-08-14